TROG 99.04/ALLG LY02 - Osteolymphoma - OL - TROG Cancer Research

Read Roland's story about participating in a prostate cancer trial

2026 Clinical Research Education Workshop (CREW) - Virtual attendance now available

Notice of AGM of the Trans Tasman Radiation Oncology Group .

First participant recruited for new lung cancer trial

By w.paterson
14 August, 2021
0 Comments

A Prospective, Non-Randomised Study of Chemotherapy and Radiotherapy for Osteolymphoma (OL)

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Related Post

26 March, 2026

TROG welcomes new Board members and President-Elect

LATEST NEWS: 26 March 2026 We are delighted to

26 March, 2026

TROG’S 38th ASM puts focus on driving innovative trials

LATEST NEWS: 26 March 2026 TROG’s 2026 Annual Scientific